Synergistic effects through targeting the PI3K and IGFR pathways in treating lung cancer carrying activation alterations along the PI3K pathway
Mohamed Abd El-Salam(Barcelona Biomedical Research Park), Chong-xian Pan(VA Boston Healthcare System)
Cited by 0
Related Papers
Combination strategies to maximize the benefits of cancer immunotherapy
|Journal of Hematology & Oncology|2021|651